The GST Waiver on Individual Life and Health Premiums: What Changed for Advisors

With effect from 22 September 2025, GST on individual life insurance and individual health insurance premiums went from 18% to zero. The exemption covers all individual life policies and all individual health policies, including family floater plans. A tax coming off a retail financial product is not a common event in India, and this one came off the two products sitting at the centre of most advisors' books.

Two things about the scope matter before anything else, because they are where the mistakes happen.

It is uniform across the individual category. All individual life, all individual health. You do not have to work out product by product whether a given individual policy qualifies.

It stops at the individual boundary. Employer-sponsored group health is not exempt and remains taxable at 18%. The exemption follows the nature of the policy (individual versus group) and the buyer (consumer versus business), not the broad label health insurance. That distinction gets its own section below, because it is the most useful thing in this post for a working advisor.

The transition ran on a payment-date basis: instalment premiums paid before 22 September 2025 attracted 18%, and premiums collected on or after that date are exempt. By mid-2026 that matters mainly when you are reconstructing an old receipt for a client querying what they paid.

What this post works through is the part the rate change does not tell you: what removing a tax from a premium does to the conversation you have, the objection you hear, and the part of your job that just got harder.

A tax on premium is a wedge between two numbers: the number the product is priced at, and the number that leaves the client's bank account. The client only ever experiences the second one.

That is not a small distinction in retail insurance, because retail insurance is sold at the moment the second number becomes real. A client can nod along to an illustration for twenty minutes and then stall at the payment screen, and what stalled them was not the illustration. It was the out-the-door figure, which was larger than the figure they had been nodding at.

Removing the tax closes that wedge. The number you quote and the number the client pays converge, and three things follow:

1. The out-the-door price falls. Whatever the client was paying, they now pay the pre-tax figure. Arithmetic, not a forecast.
2. Affordability at the point of sale improves. Some proportion of clients who previously fell off at the payment step no longer do. You will never identify which ones, because you never met the ones who quietly did not proceed.
3. The stall you used to hit moves. The friction does not disappear. It relocates, which is the part most of the commentary misses.

A fourth effect matters more than the first three: the quoted figure is now honest on its own. You are no longer naming a premium and then adding to it. That small credibility tax on you, at the moment you needed credibility most, is gone.

The reflex reading is that the sale got easier. That is half true, and the half that is not true is where advisors get caught.

The old objection, in whatever words your client used, was about the total: this costs more than I thought. Number objections are specific, and they resolve or they do not, quickly. You knew where you stood.

What replaces it is quieter and slower. When price stops being the reason to say no, clients do not simply say yes. They find the next reason, usually one of these:

• Do I actually need this much? Price used to answer this by proxy. If the client could not afford the higher sum insured, the conversation about whether they needed it never had to happen.
• Why this policy and not that one? The tax came off the individual category uniformly, so a comparison between two individual products is no longer muddied by a tax component that differs. The products are being compared on themselves.
• Why now? Affordability was a deadline substitute. Without it, deferral becomes cheap.
• Why you? If the price is the price wherever they buy it, your presence in the transaction has to justify itself on something other than the number.

Each is harder than the price question was, and none resolves in one conversation. They resolve on the strength of the recommendation, which is the actual change.

Here is the inversion, and it is the argument of this post.

A price objection is annoying but load-bearing. It gives the conversation a shape. It supplies urgency, it forces a decision, it filters, and it lets an advisor be useful in an easy way: by finding the cheaper option, the lower sum insured, the annual mode instead of the monthly one. That is genuine help, and it does not require you to have an opinion about what the client should own.

Take the price friction out and that scaffolding goes with it. The conversation is now about suitability, which is the harder discipline. It asks questions the price never asked you:

• What does this household actually need covered, and against what?
• Is this the right product, or is it the product this client walked in asking about?
• Is the sum insured right, or is it the number that fit the old budget?
• What will this client think of this policy in year four, when the novelty is gone and the renewal notice arrives?

The advisor who reads this as a reason to sell more of what they were already selling has read it wrong. The advisor who reads it as the removal of an excuse has read it right.

There is a persistency dimension too. A policy bought because the number got small enough is not a policy with a reason attached to it, and reasons are what survive to the second renewal. If affordability alone closes a sale, affordability alone is holding it, and that is not a durable thing to hold a policy with.

The waiver has a second half, worth understanding because it is the reason this change is not simply free money.

GST is a value-added tax, so an insurer collecting output tax on premium is ordinarily offsetting tax it has itself paid on its inputs. When individual life and health became exempt on 22 September 2025, two things happened at once. The policyholder stopped paying 18% on the premium. And the insurer can no longer claim input credit on the costs attributable to writing that exempt business.

Tax the insurer pays on what it buys to write this business is now a cost it absorbs rather than offsets, and an absorbed cost has to land somewhere. There are three places:

1. Product pricing, if the underlying premium moves to absorb it.
2. Expenses, if the insurer squeezes what it spends to deliver the product, which includes distribution.
3. Margin, if the insurer simply wears it.

Where it landed is genuinely open, and this post does not answer it. It likely differs by insurer, by product, and over time. Nobody knows what every insurer did with pricing across every product, whatever a comparison page implies.

What this gives you is a reason to be alert to a change you might otherwise misattribute. If a base premium on a product you place regularly moves, lost input credit is now one candidate explanation alongside claims experience, age banding, and ordinary repricing. Treat it as a hypothesis you check, never as a story you tell a client.

Note the direction of the two halves. The client's saving is certain and immediate. The insurer's lost credit is certain too, and pushes the other way. So a client comparing this year's renewal against last year's and finding the drop smaller than expected is not necessarily being cheated. The tax came off in full. The base premium is a separate number that moves for its own reasons, and lost input credit is now one of them.

This is the boundary that will actually come up in your conversations, and it is sharper than it feels.

The rule does the work: the exemption follows the nature of the policy (individual versus group) and the buyer (consumer versus business), not the broad label health insurance. Hold that and most of the errors take care of themselves.

Here is the case that will land on you. A salaried client has an employer-sponsored group health cover and an individual health policy of their own. They have read that health insurance is now GST free. They are right about half their cover and do not know which half. Individual health is exempt. Employer-sponsored group health is not, and remains taxable at 18%. Same word, same client, same conversation, different treatment, and the thing deciding it is not the cover. It is the nature of the policy and who is buying it.

That cuts in a useful direction. The individual cover a client holds alongside their group scheme got cheaper out the door; the group cover did not. For a client weighing whether their employer's cover is enough, the relative arithmetic of topping up individually has moved in favour of the top-up. That is a real conversation, and one you can now have accurately rather than vaguely.

Two things this post does not resolve. Riders: whether a rider attached to a base policy travels with the base policy's treatment is a separate question, and the answer belongs to the insurer for that product. Commercial covers: a different world, and mostly outside what you can place regardless.

The rule itself is solid and you can rely on it. The habit worth keeping is that any tax number reaching a client from the edge of that rule should be traceable to the insurer's literature rather than extended by analogy from this one.

One conflation is common enough to name directly, because it appears in advisor conversations constantly and it is a category error rather than a detail error.

The GST on the premium your client pays and the tax treatment of the remuneration you receive are two different questions. They involve different parties, different supplies, and different positions in the chain. The client's premium is a payment for an insurance contract. Your remuneration is a payment from whoever engaged you, arising from a contract of engagement. A change to one carries no automatic implication for the other, and that both are called GST is close to the whole of the resemblance.

So what is the treatment of the remuneration? This post declines to say.

That is a deliberate refusal, not a gap. A sibling post in this series looked for a sourced answer on how advisor remuneration is treated for GST and TDS, could not find one it was willing to stand behind, and declined to fill the hole with something plausible. The same applies here. The temptation to write a confident paragraph is strong precisely because it would be useful, and a wrong one about the tax treatment of your own income is worse than none at all. You would act on it.

What to do instead is concrete:

• Ask the entity that engages you how your remuneration is treated and what is deducted before it reaches you. It is their contract and their deduction.
• Get the answer against a statement you can read line by line.
• Ask a tax professional about your own position, once, properly. Your circumstances are yours and a general answer would not fit them anyway.
• Keep the two questions filed separately, so news about one never quietly becomes an assumption about the other.

Knowing which question you are answering is worth more than a memorised answer to either.

Concretely, for one person running their own book:

The quote is now the price. Say the number and stop. There is no addition step, no moment where the total grows after the client has agreed to something smaller.

Revisit the clients who said no on price. Somewhere in your book are people who got to the end and did not proceed, and the reason was the number. That reason may have changed. This is the most direct action available here, and it costs nothing but the calls. Approach them with what suits them, not with the news that something got cheaper.

Watch for sum insured drift. The client whose budget previously capped their cover now has room. Whether that room should be filled is a suitability question with a real answer, and the answer is sometimes no. Ask it deliberately rather than letting the room fill itself.

Do not build a pitch on the tax. A pitch built on a tax position has an expiry date you do not control. Build on the cover, which is what the client is buying and what will still be true next year.

Have one honest sentence ready. Close to: your individual life and health policies are exempt, your employer's group cover is not, and I will confirm anything at the edge of that before you pay. Short, accurate, and more than most of what your client has read on the subject.

The waiver is good news for people who could not previously afford cover they needed, and there is no reason to be grudging about it. It is also a quiet removal of a support your sales conversation was leaning on more than you probably noticed. Both are true, and the advisors who do well from here will be the ones who noticed the second thing.